J.P. Morgan Comments On CI Investors Day

On Friday, CIGNA Corporation CI held an investor day, reiterating the already established key '11 guidance points and also setting a long-term EPS growth target at 10-13%, J.P. Morgan reports.

J.P. Morgan said that among some of the key themes it noted:

“1) The International business getting the top billing, with differentiated growth potential and market positioning;

“2) Making progress with VADBe book (run-off reinsurance) and, in our view, tracking to get a permanent fix (we still believe can get it done in '11), a factor that we continue to view as important to the stock valuation;

“3) On the Health book, positioning '11 as a year for continued growth, as opposed to rebasement, while retaining a significant heavy bias toward commercial group business, with government-program (Medicare & Medicaid) still more of a future consideration, while we believe this ultimately has to be an important part of the mix for a diversified, large-cap health benefits company. Our earnings outlook is unchanged and following we include the highlights.”

CIGNA Corporation closed Friday at $43.57.